Print Page     Close Window     

Investor Overview

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. With an unmatched understanding of muscle biology and mechanics of muscle performance, the company is developing small molecule drug candidates specifically engineered to increase muscle function and contractility. More >>

Annual Report & Stockholder Meeting Materials and Information


© 2015 Cytokinetics, Inc. All rights reserved